CWCurtis H. Weiss

Curtis H. Weiss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Curtis H. Weiss has a total of 187 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Multidisciplinary Survey Comparing Academic and Community Critical Care Clinicians’ Acute Respiratory Distress Syndrome Practice and the COVID-19 Pandemic

    by Diane Masket, Carey C. Thomson, Andre Carlos Kajdacsy-Balla Amaral, Catherine L. Hough, Nicholas J. Johnson, David A. Kaufman, Jonathan M. Siner, Jennifer P. Stevens, Lipisha Agarwal, Peymaan Banankhah, et al.

    Rationale: Barriers to recognizing and treating acute respiratory distress syndrome (ARDS) exist. Prior studies have not investigated whether these barriers differ between academic and community settings or whether there were differences in critical care clinicians’ reported ARDS management strategies during the coronavirus disease (COVID-19) pandemic. Objectives: Grounded in the Consolidated Framework for Implementation Research, we sought to determine whether there are differences between academic and community critical care clinicians in their team- and intensive care unit (ICU)-based culture; interprofessional communication; knowledge, attitudes, and perceived barriers to ARDS recognition and management; and ICU organization and ARDS management associated with the COVID-19 pandemic. Methods: Multidisciplinary survey from September 2020 to April 2021 of critical care physicians, nurses, advanced practice providers, and respiratory therapists (RTs) in six academic and nine community hospitals across the United States and Canada. Individual item and cumulative domain scores were compared between academic and community clinicians. Statistical adjustment was performed for multiple comparisons. Results: A total of 1,906 clinicians responded to at least one survey item (53% response rate). Mean (standard deviation [SD]) culture scores were higher for community physicians versus academic physicians (5.3 [1.8] vs. 4.4 [2.0]; P < 0.001) and community nurses versus academic nurses (4.4 [2.2] vs. 3.8 [2.1]; P = 0.007). Academic nurses and RTs had higher knowledge scores than community nurses and RTs (P < 0.001 for each comparison). Community physicians, nurses, and RTs reported higher mean (SD) number of changes in ICU organization and practice during the COVID-19 pandemic than academic clinicians (e.g., community physicians: 13.7 [2.7] changes vs. academic physicians: 11.8 [4.3] changes; P = 0.001). Although academic physicians, nurses, and RTs were approximately twice as likely to care for patients with ARDS daily or several days per week compared with community clinicians, ARDS management, attitudes, and belief in evidence was similar between academic and community clinicians in most respects. Conclusions: A large, multidisciplinary survey identified differences between academic and community critical care clinicians’ culture and knowledge in the care of patients with ARDS. The COVID-19 pandemic had a greater impact on community ICU organization and ARDS management. Multifaceted implementation strategies should target implementation barriers differently in academic and community settings.


  • Open Access

    Open-source computational pipeline flags instances of acute respiratory distress syndrome in mechanically ventilated adult patients

    by Félix L. Morales, Feihong Xu, Hyojun Ada Lee, Helio Tejedor Navarro, Meagan A. Bechel, Eryn L. Cameron, Jesse Kelso, Curtis H. Weiss, Luís A. Nunes Amaral

    Physicians in critical care settings face information overload and decision fatigue, contributing to under-recognition of acute respiratory distress syndrome, which affects over 10% of intensive care patients and carries over 40% mortality rate. We present a reproducible computational pipeline to automatically identify this condition retrospectively in mechanically ventilated adults. This computational pipeline operationalizes the Berlin Definition by detecting bilateral infiltrates from radiology reports and a pneumonia diagnosis from attending physician notes, using interpretable classifiers trained on labeled data. Here we show that our integrated pipeline achieves high performance-93.5% sensitivity and 17.4% false positive rate-when applied to a held-out and publicly-available dataset from an external hospital. This substantially exceeds the 22.6% documentation rate observed in the same cohort. These results demonstrate that our automated adjudication pipeline can accurately identify an under-diagnosed condition in critical care and may support timely recognition and intervention through integration with electronic health records.


  • Open Access

    Open-source computational pipeline automatically flags instances of acute respiratory distress syndrome from electronic health records

    by Félix L. Morales, Feihong Xu, Hyojun Ada Lee, Heliodoro Tejedor Navarro, Meagan A. Bechel, Eryn L. Cameron, Jesse D. Kelso, Curtis H. Weiss, Luís A. Nunes Amaral

    Physicians, particularly intensivists, face information overload and decision fatigue, underscoring the need for automated diagnostic tools. Acute Respiratory Distress Syndrome (ARDS) affects over 10% of critical care patients, with over 40% mortality rate, yet is only recognized in 30-70% of cases in clinical settings. We present a reproducible computational pipeline that automates ARDS adjudication in retrospective datasets of mechanically ventilated adults, implementing the Berlin Definition via natural language processing and classification algorithms. We used labeled chest imaging reports from two hospitals to train an XGBoost model to detect bilateral infiltrates, and a labeled subset of attending physician notes from one hospital to train another XGBoost model to detect a pneumonia diagnosis. Both models achieve high discriminative performance on test sets—an area under the receiver operating characteristic curve (AUROC) of 0.88 for adjudicating bilateral infiltrates on chest imaging reports, and an AUROC of 0.87 for detecting pneumonia on attending physician notes. We integrated these models with rule-based components and validated the entire pipeline on a subset of healthcare encounters from a third hospital (MIMIC-III). We find a sensitivity of 93.5% in adjudicating ARDS — far surpassing the 22.6% ARDS documentation rate we found for this cohort — along with a false positive rate of 17.4%. We conclude that our reproducible, automated pipeline holds promise for improving ARDS recognition and could aid clinical practice through real-time EHR integration.

  • Top Cited Papers
    Open Access

    Defining the Time-Limited Trial for Patients with Critical Illness: An Official American Thoracic Society Workshop Report

    by Jacqueline M. Kruser, Deepshikha C. Ashana, Katherine R. Courtright, Erin K. Kross, Thanh H. Neville, Eileen Rubin, Yael Schenker, Donald R. Sullivan, J. Daryl Thornton, Elizabeth M. Viglianti, et al.

    In critical care, the specific, structured approach to patient care known as a “time-limited trial” has been promoted in the literature to help patients, surrogate decision makers, and clinicians navigate consequential decisions about life-sustaining therapy in the face of uncertainty. Despite promotion of the time-limited trial approach, a lack of consensus about its definition and essential elements prevents optimal clinical use and rigorous evaluation of its impact. The objectives of this American Thoracic Society Workshop Committee were to establish a consensus definition of a time-limited trial in critical care, identify the essential elements for conducting a time-limited trial, and prioritize directions for future work. We achieved these objectives through a structured search of the literature, a modified Delphi process with 100 interdisciplinary and interprofessional stakeholders, and iterative committee discussions. We conclude that a time-limited trial for patients with critical illness is a collaborative plan among clinicians and a patient and/or their surrogate decision makers to use life-sustaining therapy for a defined duration, after which the patient’s response to therapy informs the decision to continue care directed toward recovery, transition to care focused exclusively on comfort, or extend the trial’s duration. The plan’s 16 essential elements follow four sequential phases: consider, plan, support, and reassess. We acknowledge considerable gaps in evidence about the impact of time-limited trials and highlight a concern that if inadequately implemented, time-limited trials may perpetuate unintended harm. Future work is needed to better implement this defined, specific approach to care in practice through a person-centered equity lens and to evaluate its impact on patients, surrogates, and clinicians.


  • Open Access

    Validation of a tool for estimating clinician recognition of ARDS using data from the international LUNG SAFE study

    by Meagan A. Bechel, Fabiana Madotto, Adam R. Pah, Giacomo Bellani, John G. Laffey, Tài Pham, Luís A. Nunes Amaral, Curtis H. Weiss

    Under-recognition of acute respiratory distress syndrome (ARDS) by clinicians is an important barrier to adoption of evidence-based practices such as low tidal volume ventilation. The burden created by the COVID-19 pandemic makes it even more critical to develop scalable data-driven tools to improve ARDS recognition. The objective of this study was to validate a tool for accurately estimating clinician ARDS recognition rates using discrete clinical characteristics easily available in electronic health records. We conducted a secondary analysis of 2,705 ARDS and 1,261 non-ARDS hypoxemic patients in the international LUNG SAFE cohort. The primary outcome was validation of a tool that estimates clinician ARDS recognition rates from health record data. Secondary outcomes included the relative impact of clinical characteristics on tidal volume delivery and clinician documentation of ARDS. In both ARDS and non-ARDS patients, greater height was associated with lower standardized tidal volume (mL/kg PBW) (ARDS: adjusted β = -4.1, 95% CI -4.5 –-3.6; non-ARDS: β = -7.7, 95% CI -8.8 –-6.7, PPP<0.00009) in ARDS patients. Increasing chest imaging opacities, plateau pressure, and clinician documentation of ARDS also were associated with lower tidal volume in ARDS patients. Our EHR-based data-driven approach using height, gender, ARDS documentation, and lowest standardized tidal volume yielded estimates of clinician ARDS recognition rates of 54% for mild, 63% for moderate, and 73% for severe ARDS. Our tool replicated clinician-reported ARDS recognition in the LUNG SAFE study, enabling the identification of ARDS patients at high risk of being unrecognized. Our approach can be generalized to other conditions for which there is a need to increase adoption of evidence-based care.


  • Open Access

    The first step is recognizing there is a problem: a methodology for adjusting for variability in disease severity when estimating clinician performance

    by Meagan Bechel, Adam R. Pah, Stephen D. Persell, Curtis H. Weiss, Luís A. Nunes Amaral

    Background: Adoption of innovations in the field of medicine is frequently hindered by a failure to recognize the condition targeted by the innovation. This is particularly true in cases where recognition requires integration of patient information from different sources, or where disease presentation can be heterogeneous and the recognition step may be easier for some patients than for others. Methods: We propose a general data-driven metric for clinician recognition that accounts for the variability in patient disease severity and for institutional standards. As a case study, we evaluate the ventilatory management of 362 patients with acute respiratory distress syndrome (ARDS) at a large academic hospital, because clinician recognition of ARDS has been identified as a major barrier to adoption to evidence-based ventilatory management. We calculate our metric for the 48 critical care physicians caring for these patients and examine the relationships between differences in ARDS recognition performance from overall institutional levels and provider characteristics such as demographics, social network position, and self-reported barriers and opinions. Results: Our metric was found to be robust to patient characteristics previously demonstrated to affect ARDS recognition, such as disease severity and patient height. Training background was the only factor in this study that showed an association with physician recognition. Pulmonary and critical care medicine (PCCM) training was associated with higher recognition (β = 0.63, 95% confidence interval 0.46–0.80, p < 7 × 10− 5). Non-PCCM physicians recognized ARDS cases less frequently and expressed greater satisfaction with the ability to get the information needed for making an ARDS diagnosis (p < 5 × 10− 4), suggesting that lower performing clinicians may be less aware of institutional barriers. Conclusions: We present a data-driven metric of clinician disease recognition that accounts for variability in patient disease severity and for institutional standards. Using this metric, we identify two unique physician populations with different intervention needs. One population consistently recognizes ARDS and reports barriers vs one does not and reports fewer barriers.


  • Open Access

    Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement

    by Andrea S. Gershon, Peter K. Lindenauer, Kevin C. Wilson, Louise Rose, Allan J. Walkey, Mohsen Sadatsafavi, Kevin J. Anstrom, David H. Au, Bruce G. Bender, M. Alan Brookhart, et al.

    Rationale: Decisions in medicine are made on the basis of knowledge and reasoning, often in shared conversations with patients and families in consideration of clinical practice guideline recommendations, individual preferences, and individual goals. Observational studies can provide valuable knowledge to inform guidelines, decisions, and policy. Objectives: The American Thoracic Society (ATS) created a multidisciplinary ad hoc committee to develop a research statement to clarify the role of observational studies—alongside randomized controlled trials (RCTs)—in informing clinical decisions in pulmonary, critical care, and sleep medicine. Methods: The committee examined the strengths of observational studies assessing causal effects, how they complement RCTs, factors that impact observational study quality, perceptions of observational research, and, finally, the practicalities of incorporating observational research into ATS clinical practice guidelines. Measurements and Main Results: There are strengths and weakness of observational studies as well as RCTs. Observational studies can provide evidence in representative and diverse patient populations. Quality observational studies should be sought in the development of ATS clinical practice guidelines, and medical decision-making in general, when 1) no RCTs are identified or RCTs are appraised as being of low- or very low-quality (replacement); 2) RCTs are of moderate quality because of indirectness, imprecision, or inconsistency, and observational studies mitigate the reason that RCT evidence was downgraded (complementary); or 3) RCTs do not provide evidence for outcomes that a guideline committee considers essential for decision-making (e.g., rare or long-term outcomes; “sequential”). Conclusions: Observational studies should be considered in developing clinical practice guidelines and in making clinical decisions.


  • Open Access

    Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM

    by Richard G. Wunderink, Arjun Srinivasan, Philip S. Barie, Jean Chastre, Charles S. Dela Cruz, Ivor S. Douglas, Margaret Ecklund, Scott E. Evans, Scott R. Evans, Anthony T. Gerlach, et al.

    Intensive care units (ICUs) are an appropriate focus of antibiotic stewardship program efforts because a large proportion of any hospital’s use of parenteral antibiotics, especially broad-spectrum, occurs in the ICU. Given the importance of antibiotic stewardship for critically ill patients and the importance of critical care practitioners as the front line for antibiotic stewardship, a workshop was convened to specifically address barriers to antibiotic stewardship in the ICU and discuss tactics to overcome these. The working definition of antibiotic stewardship is “the right drug at the right time and the right dose for the right bug for the right duration.” A major emphasis was that antibiotic stewardship should be a core competency of critical care clinicians. Fear of pathogens that are not covered by empirical antibiotics is a major driver of excessively broad-spectrum therapy in critically ill patients. Better diagnostics and outcome data can address this fear and expand efforts to narrow or shorten therapy. Greater awareness of the substantial adverse effects of antibiotics should be emphasized and is an important counterargument to broad-spectrum therapy in individual low-risk patients. Optimal antibiotic stewardship should not focus solely on reducing antibiotic use or ensuring compliance with guidelines. Instead, it should enhance care both for individual patients (by improving and individualizing their choice of antibiotic) and for the ICU population as a whole. Opportunities for antibiotic stewardship in common ICU infections, including community- and hospital-acquired pneumonia and sepsis, are discussed. Intensivists can partner with antibiotic stewardship programs to address barriers and improve patient care.


  • Open Access

    Performance Measure Development, Use, and Measurement of Effectiveness Using the Guideline on Mechanical Ventilation in Acute Respiratory Distress Syndrome. An Official American Thoracic Society Workshop Report

    by Kathryn A. Artis, Raed A. Dweik, Bela Patel, Curtis H. Weiss, Kevin C. Wilson, Anna R. Gagliardi, Sue Huckson, Monika Nothacker, Neill K. J. Adhikari, Andre Carlos Kajdacsy-Balla Amaral, et al.

    Guideline implementation tools are designed to improve uptake of guideline recommendations in clinical settings but do not uniformly accompany the clinical practice guideline documents. Performance measures are a type of guideline implementation tool with the potential to catalyze behavior change and greater adherence to clinical practice guidelines. However, many performance measures suffer from serious flaws in their design and application, prompting the American Thoracic Society (ATS) to define its own performance measure development standards in a previous workshop in 2012. This report summarizes the proceedings of a follow-up workshop convened to advance the ATS’s work in performance measure development and guideline implementation. To illustrate the application of the ATS’s performance measure development framework, we used the example of a low–tidal volume ventilation performance measure created de novo from the 2017 ATS/European Society of Intensive Care Medicine/Society of Critical Care Medicine mechanical ventilation in acute respiratory distress syndrome clinical practice guideline. We include a detailed explanation of the rationale for the specifications chosen, identification of areas in need of further validity testing, and a preliminary strategy for pilot testing of the performance measure. Pending additional resources and broader performance measure expertise, issuing “preliminary performance measures” and their specifications alongside an ATS clinical practice guideline offers a first step to further the ATS’s guideline implementation agenda. We recommend selectively proceeding with full performance measure development for those measures with positive early user feedback and the greatest potential impact in accordance with ATS leadership guidance.


  • Open Access

    A quantitative approach for the analysis of clinician recognition of acute respiratory distress syndrome using electronic health record data

    by Meagan A. Bechel, Adam R. Pah, Hanyu Shi, Sanjay Mehrotra, Stephen D. Persell, Shayna Weiner, Richard G. Wunderink, Luís A. Nunes Amaral, Curtis H. Weiss

    Despite its efficacy, low tidal volume ventilation (LTVV) remains severely underutilized for patients with acute respiratory distress syndrome (ARDS). Physician under-recognition of ARDS is a significant barrier to LTVV use. We propose a computational method that addresses some of the limitations of the current approaches to automated measurement of whether ARDS is recognized by physicians. To quantify patient and physician factors affecting physicians’ tidal volume selection and to build a computational model of physician recognition of ARDS that accounts for these factors. In this cross-sectional study, electronic health record data were collected for 361 ARDS patients and 388 non-ARDS hypoxemic (control) patients in nine adult intensive care units at four hospitals between June 24 and December 31, 2013. Standardized tidal volumes (mL/kg predicted body weight) were chosen as a proxy for physician decision-making behavior. Using data-science approaches, we quantified the effect of eight factors (six severity of illness, two physician behaviors) on selected standardized tidal volumes in ARDS and control patients. Significant factors were incorporated in computational behavioral models of physician recognition of ARDS. Hypoxemia severity and ARDS documentation in physicians’ notes were associated with lower standardized tidal volumes in the ARDS cohort. Greater patient height was associated with lower standardized tidal volumes (which is already normalized for height) in both ARDS and control patients. The recognition model yielded a mean (99% confidence interval) physician recognition of ARDS of 22% (9%-42%) for mild, 34% (19%-49%) for moderate, and 67% (41%-100%) for severe ARDS. In this study, patient characteristics and physician behaviors were demonstrated to be associated with differences in ventilator management in both ARDS and control patients. Our model of physician ARDS recognition measurement accounts for these clinical variables, providing an electronic approach that moves beyond relying on chart documentation or resource intensive approaches.